Filing Details
- Accession Number:
- 0001441844-10-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-12-01 16:12:36
- Reporting Period:
- 2010-12-01
- Filing Date:
- 2010-12-01
- Accepted Time:
- 2010-12-01 16:12:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 835887 | Progenics Pharmaceuticals Inc | PGNX | Pharmaceutical Preparations (2834) | 133379479 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1250313 | J Paul Maddon | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chief Executive Officer/Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-12-01 | 5,000 | $4.90 | 854,057 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This transaction was executed in multiple trades at prices ranging from $4.85 to $4.98. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
